Therefore, we can consider combining different CENPs in clinical practice to improve the diagnostic and prognostic value of HCC and can also combine AFP and abnormal prothrombin for early diagnosis and prognosis assessment. This evidence concerns the gene AFP and hepatocellular carcinoma.